Publications by authors named "Lisa Ley"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

603

Total Likes

450

Extended Reach

3,992,965

Social Features

198
A
A phase 2 study of sacituzumab govitecan with or without atezolizumab in rare genitourinary tumors (SMART) - design and rationale.
Andre R Kydd, Elias Chandran, Nicholas I Simon, Saad Atiq, Lisa Ley

Future Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
E-VIRTUE: a study of enfortumab vedotin with or without pembrolizumab in rare genitourinary tumors-design and rationale.
Elias B A Chandran, Saad Atiq, Nicholas Simon, Daniel Girardi, Lisa Ley

Future Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pan-cancer prediction of tumor immune activation and response to immune checkpoint blockade from tumor transcriptomics and histopathology.
Sumit Mukherjee, Sumeet Patiyal, Lipika R Pal, Tian-Gen Chang, Sumona Biswas, Lisa Ley

bioRxiv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of lurbinectedin with or without avelumab in small cell carcinoma of the bladder (laser)-design and rationale.
Nicholas Simon, Elias Chandran, Saad Atiq, Andre R Kydd, Daniel Girardi, Lisa Ley

Future Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors.
Andrea B Apolo, Daniel M Girardi, Scot A Niglio, Rosa Nadal, Andre R Kydd, Lisa Ley, James L Gulley

J Clin Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy.
Daniel M Girardi, Scot A Niglio, Amir Mortazavi, Rosa Nadal, Primo Lara, Lisa Ley

Clin Cancer Res· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Tumor Cell Subtypes and T-cell Populations as Prognostic Biomarkers to Combination Immunotherapy in Patients with Metastatic Genitourinary Cancer.
Heather J Chalfin, Tiziano Pramparo, Amir Mortazavi, Scot A Niglio, Joseph D Schonhoft, Lisa Ley, James L Gulley

Clin Cancer Res· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors.
Andrea B Apolo, Rosa Nadal, Daniel M Girardi, Scot A Niglio, Lisa Ley, James L Gulley

J Clin Oncol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating microRNA profile predicts disease progression in patients receiving second-line treatment of lapatinib and capecitabine for metastatic pancreatic cancer.
Xuefei Tian, Narayan Shivapurkar, Zheng Wu, Jimmy J Hwang, Michael J Pishvaian, Lisa Ley

Oncol Lett· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of lapatinib and capecitabine in second-line treatment for metastatic pancreatic cancer.
Zheng Wu, Andrew Gabrielson, Jimmy J Hwang, Michael J Pishvaian, Louis M Weiner, Lisa Ley

Cancer Chemother Pharmacol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Pancreatic Cancer-Associated Stellate Cells Remain Activated after in vivo Chemoradiation.
M Carla Cabrera, Estifanos Tilahun, Rebecca Nakles, Edgar S Diaz-Cruz, Aline Charabaty, Lisa Ley

Front Oncol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic body radiation therapy with concurrent full-dose gemcitabine for locally advanced pancreatic cancer: a pilot trial demonstrating safety.
Marie K Gurka, Sean P Collins, Rebecca Slack, Gary Tse, Aline Charabaty, Lisa Ley

Radiat Oncol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis